MAINZ, Germany–(BUSINESS WIRE)–BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, announced today that it has signed an agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to Read More
Year: 2019
BASF, MedAccess and the Bill & Melinda Gates Foundation collaborate to bring innovative mosquito nets to malaria-endemic countries
To mark the Sixth Replenishment Conference of The Global Fund to Fight AIDS, Tuberculosis and Malaria, BASF, MedAccess and the Bill & Melinda Gates Foundation have announced an agreement that will facilitate the supply of 35 million Interceptor® G2 mosquito Read More
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
XCONOMY SAN FRANCISCO – Vir Biotechnology has joined the public markets, raising $142.9 million to support clinical tests of its infectious disease drugs. Read the full press release here.
Press Release: AgBiome Awarded Phase II Grant to Combat Major Pest of African Subsistence Crops
RESEARCH TRIANGLE PARK, N.C., September 12, 2019 — AgBiome, Inc., a leader in harnessing the plant microbiome, has received Phase II grant funding from the Bill & Melinda Gates Foundation to continue the discovery of microbes that target sweetpotato weevils Read More
Press Release: Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis
University of California, Davis Study Shows up to 98% Reduction of Intestinal Inflammation Markers Linked to Colic, Eczema, Asthma and Diabetes DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ — Findings from a new study published today in Pediatric Research show that feeding activated Read More
Press Release: Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants
Breakthrough Study Reveals Activated B. infantis EVC001 as the First Infant Probiotic to Be Effective in the Fight Against Global Health Epidemic DAVIS, Calif., Aug. 14, 2019 /PRNewswire/ — Evolve BioSystems, Inc. today announced findings from a new study that identified Read More
Press Release: Medicines Development for Global Health Discloses Novo Nordisk as Purchaser of its Priority Review Voucher
Significant portion of proceeds will be reinvested in neglected disease research and control efforts, fully realizing the original intent of this important public health funding mechanism Melbourne, Australia, 9 August 2019 – Today, in conjunction with its second quarter financial Read More
Bloomberg: Bill Gates and Former Bass Guitarist Aim to Change Health Care
By Yoolim Lee and David Ramli July 24, 2019 Jonathan Sudharta was a brawl-prone, unremarkable student who played in a rock band. Friends of his father, a self-made tycoon, feared he’d one day take over the family medical business and ruin Read More
Nasdaq: Solid tumor biotech Atreca files for a $100 million IPO
May 24, 2019 Atreca, a preclinical biotech developing immunotherapies for solid tumors, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Redwood City, CA-based company was founded in 2010 and plans Read More
New York Times: In African Villages, These Phones Become Ultrasound Scanners
By Donald G. McNeil Jr. April 15, 2019 BUSHORO, Uganda — Lying on a church pew with his arm over his head, 6-year-old Gordon Andindagaye whimpered a bit — in fear, not pain — as Dr. William A. Cherniak slowly swept Read More